Conference abstractPublished 2 Jul 2012
Development of an in silico model for predicting activation of promiscuous drug transporter hPXR
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The nuclear receptor pregnane X receptor (PXR) is referred to as the �master� regulator of pathways involving the major metabolic enzymes and can be activated by a wide range of structurally diverse endogenous and xenobiotic molecules. In addition, the activation of PXR has significant impact on drug metabolism and efflux as well as drug-drug interactions. Identification of PXR activators is of critical importance in analyzing metabolism and pharmacokinetic profiles and detecting potential adverse drug-drug interactions in the process of drug discovery and development, which, however, cannot be accurately modeled without taking into account the promiscuous nature of hPXR. A predictive model was derived to predict the activation of hPXR using the novel pharmacophore ensemble/support vector machine (PhE/SVM) scheme. The derived PhE/SVM model is an accurate and robust predictive model as manifested by those samples in the training set, test set, and outlier set. Furthermore, the calculated results are consistent with the published hPXR-ligand cocomplex structure and the plasticity nature of hPXR is also revealed when compared with crystal structures.
Subjects
Biochemistry & BiotechnologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Proteomics & Bioinformatics
- SubjectBiochemistry & Biotechnology
- BylineArticles whose byline prints “Max K. Leong”
